Takeda Ventures logo

Takeda Ventures

North America, California, United States, San Diego

Description

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Investor Profile

Takeda Ventures has made 92 investments, with 4 in the past 12 months and 18% as lead.

Stage Focus

  • Series A (35%)
  • Series B (20%)
  • Series Unknown (15%)
  • Series C (11%)
  • Seed (8%)
  • Series D (7%)
  • Post Ipo Equity (2%)
  • Private Equity (1%)
  • Debt Financing (1%)
  • Convertible Note (1%)

Country Focus

  • United States (73%)
  • United Kingdom (10%)
  • Israel (5%)
  • Canada (2%)
  • Japan (2%)
  • Denmark (1%)
  • France (1%)
  • Spain (1%)
  • The Netherlands (1%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Oncology
  • Biopharma
  • Medical Device
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Takeda Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 9
Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 5
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 5
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 5
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 5
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 6

Which angels does Takeda Ventures often collaborate with?

David Pyott
North America, California, United States, Orange
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by Takeda Ventures?

Harness Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

BiotechnologyLife Science
Series UnknownJan 27, 2025
Degron Therapeutics

Shanghai, Shanghai, China

Degron Therapeutics is a platform company in discovery of molecular glue degraders for cancer treatment.

BiotechnologyHealth CareOncology
Series AJan 22, 2025
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series CJan 15, 2025
Amount Raised: $92,000,000
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series UnknownOct 22, 2024
Amount Raised: $82,000,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series UnknownNov 16, 2023
Amount Raised: $37,398,371
Larkspur Biosciences

Watertown, Massachusetts, United States

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

BiotechnologyHealth CareMedical
Series AMay 23, 2023
Amount Raised: $35,500,000
OncoResponse

Seattle, Washington, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

BiopharmaBiotechnologyHealth CareOncologyTherapeutics
Series DMay 18, 2023
Amount Raised: $14,000,000
Cerevance

Boston, Massachusetts, United States

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series BFeb 13, 2023
Amount Raised: $51,000,000
Ensoma

Boston, Massachusetts, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

BiotechnologyGeneticsLife ScienceMedicalOncologyTherapeutics
Series BJan 5, 2023
Amount Raised: $85,000,000
hC Bioscience

Cambridge, Massachusetts, United States

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

BiotechnologyHealth CareLife Science
Series ANov 4, 2022
Amount Raised: $16,000,000